Despite premium seats topping $400, top global opera institutions face widening structural deficits driven by Baumol's cost disease and shifting patronage.

Studio executives and streaming platforms are capitalizing on corporate malfeasance, turning high-profile Silicon Valley collapses into profitable cultural franchises.